Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for the upadacitinib study is available, including its study design, participant criteria, locations, outcome measures, and data-sharing documents, rather than displaying a forbidden error page.
    Difference
    77%
    Check dated 2026-11-09T12:50:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2, while the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:25:20.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice announces updates about the NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-26T11:45:20.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:40:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:27.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The Study Record page now shows a 403 Forbidden error, replacing the previously visible study details and related navigation.
    Difference
    19%
    Check dated 2026-09-21T20:38:33.000Z thumbnail image

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.